Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KY100001 in Advanced Solid Tumors
NCT04906473Phase 1Unknown
- Start
- Jul 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of KY100001 in solid tumor (advanced stage), cholangiocarcinoma (CCA) and glioma. Primary endpoints: Number of subjects with abnormal vital signs at 12 weeks, Number of subjects with abnormal physical examination at 12 weeks and 3 more. Status: unknown.
02
Drugs
KY100001
03
Conditions
solid tumor (advanced stage)cholangiocarcinoma (CCA)glioma
Beyond the preview
Go deeper on NCT04906473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906473.